The NetherLands Registry of Invasive Coronary Vasomotor Function Testing (NL-CFT)
NCT ID: NCT06083155
Last Updated: 2024-05-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
2000 participants
OBSERVATIONAL
2020-10-15
2035-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Physiological Patterns of Coronary Artery Disease
NCT03824600
Observational Registry on Clinical Outcome After Diagnosis of Chronic Total Occlusions
NCT04145167
The REAL Registry for Utilization of iFR in Assessing Coronary Stenoses
NCT02281110
Fractional Flow Reserve Fax Registry
NCT03055910
Angiography-Derived FFR And IVUS for Clinical Outcomes in Patients With Coronary Artery Disease
NCT04397211
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Normal CFT results: no coronary vasomotor dysfunction
Collection of data on anginal complaints, use of medication and major adverse cardiac events (MACE) by means of online patient questionnaires
Coronary Function Test
All participants are referred for a clinically indicated coronary function test
Patient questionnaires
All participants that consent will receive yearly followup questionnaires for 5 years after their initial consent
Abnormal CFT results: coronary vasomotor dysfunction
Comparison of patient reported outcomes of different endotype groups Collection of data on anginal complaints, use of medication and MACE by means of online patient questionnaires
Coronary Function Test
All participants are referred for a clinically indicated coronary function test
Patient questionnaires
All participants that consent will receive yearly followup questionnaires for 5 years after their initial consent
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Coronary Function Test
All participants are referred for a clinically indicated coronary function test
Patient questionnaires
All participants that consent will receive yearly followup questionnaires for 5 years after their initial consent
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
UMC Utrecht
OTHER
Catharina Ziekenhuis Eindhoven
OTHER
Maasstad Hospital
OTHER
VieCuri Medical Centre
OTHER
Frisius Medisch Centrum
OTHER
Haaglanden Medical Centre
OTHER
Rijnstate Hospital
OTHER
Medisch Spectrum Twente
OTHER
Onze Lieve Vrouwe Gasthuis
OTHER
Tergooi Hospital
OTHER
Amphia Hospital
OTHER
Elisabeth-TweeSteden Ziekenhuis
OTHER
Noordwest Ziekenhuisgroep
OTHER
Amsterdam University Medical Centers (UMC), Location Academic Medical Center (AMC)
OTHER
Radboud University Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Peter Damman
Role: PRINCIPAL_INVESTIGATOR
Radboud University Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
RadboudUMC
Nijmegen, Gelderland, Netherlands
Amsterdam UMC
Amsterdam, , Netherlands
Onze Lieve Vrouwe Gasthuis (OLVG)
Amsterdam, , Netherlands
Rijnstate Hospital
Arnhem, , Netherlands
Amphia Hospital
Breda, , Netherlands
Catharina Ziekenhuis
Eindhoven, , Netherlands
Medisch Spectrum Twente
Enschede, , Netherlands
Tergooi Hospital
Hilversum, , Netherlands
Medisch Centrum Leeuwarden
Leeuwarden, , Netherlands
Maastricht UMC
Maastricht, , Netherlands
Maasstad Ziekenhuis
Rotterdam, , Netherlands
Haaglanden Medisch Centrum
The Hague, , Netherlands
Elisabeth-TweeSteden Hospital
Tilburg, , Netherlands
UMC Utrecht
Utrecht, , Netherlands
VieCuri Medisch Centrum
Venlo, , Netherlands
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Crooijmans C, Jansen TPJ, Meeder JG, Paradies V, de Vos AMJ, Woudstra P, Vossenberg TNE, van de Hoef TP, Vos NS, Olde Bijvank EGM, van den Oord SCH, Winkler P, Meuwissen M, Widdershoven JWMG, Arkenbout EK, Stoel MG, Appelman Y, Beijk MAM, Cetinyurek-Yavuz A, den Ruijter HM, Elias-Smale SE, van Royen N, Dimitriu-Leen AC, Damman P; for NL-CFT. Angina Severity and Symptom Improvement Are Associated With Diagnostic Acetylcholine Provocation Dose in Vasospastic Angina. J Am Heart Assoc. 2025 Jan 21;14(2):e037913. doi: 10.1161/JAHA.124.037913. Epub 2025 Jan 16.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
79233
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.